Deleted Tweets From Scott Gottlieb, R-D.C.

RT @RareDiseases: “Without patient perspective, there is no good medical product development.” Rachel Sherman @US_FDA Principal Deput… https://t.co/O37tSGOVPz

UPDATE: As #HurricaneMichael moved through the Southeast, #FDA identified additional FDA-related facilities in MD, DE, VA & the Carolinas. There are more than 3,500 FDA-regulated facilities in those states that we’ve begun assessing in addition to firms identified in FL, AL & GA.

RT @FDAPatientinfo: Samir Shaikh, Deputy Director of the Patient Affairs Staff (PAS) discusses FDA’s Rare Disease Patient Listening Ses… https://t.co/1dD8M8oJpf

To date, there are no national shortages reported of any critical medical products as a result of Hurricane Michael. #FDA continues to work closely with HHS partners to assist in #HurricaneMichael response.

We have updated information for farmers in MD, DE, VA and the Carolinas on crops harvested from flooded fields for food: https://t.co/EjRCHaB4gw  and animal food: https://t.co/VIAF1a7EKZ

RT @FDATobacco: October is #HealthyLungMonth Smoking can result in lung cancer. Discover more about smoking and lung cancer here:… https://t.co/yapoV0raD6

RT @SeemaCMS: .@CMSGov, we’ve been working hard to ensure seniors benefit from more choices, more benefits & lower costs. For 201… https://t.co/vd95j5pTgO

A heart wrenching obituary that captures the pain, personal devastation, and lost promise dispensed by the opioid crisis https://t.co/ezLFW5LjCQ

FDA’s Patient Listening Sessions allow patients and their advocates to share your experience living with a rare disease with #FDA review staff. Contact the Patient Affairs Staff to learn more #NORDSummit https://t.co/3hQDiDUFk0

My op ed in The Washington Post with @SecAzar on the steps we’re taking to reverse what’s become an epidemic trajectory of kids use of e-cigarettes @washingtonpost https://t.co/DoqUjDet6Z

We issued new guidances to modernize drug development, providing greater clarity and direction as drug developers pursue the next generation of therapies and treatments for patients https://t.co/zdXvVmVhfY https://t.co/REiToTODH6

.@SecAzar: "I am very disturbed by what I am seeing in terms of e-cigarette and vaping use among our teens." https://t.co/tdUbNH9IUK

For fiscal year 2018, the #FDA approved more generic drugs applications than ever before – 971 final and tentative approvals -- beating the agency’s previous record for FY2017. About 12% of these approvals were for typically higher-cost, complex products https://t.co/yHUQnqWcBG

2/2 This list shows molecular targets for which drugs are currently being developed for adult #cancer indications and whose targets may also contribute to the growth and/or progression of #PediatricCancer: https://t.co/kPVocxr11f

THREAD 1/2 Pediatric cancer drug development has lagged far behind development of cancer drugs for adults. To help industry develop new drug and biologic products for children with cancer, @FDAOncology has posted a list of molecular targets. https://t.co/wrqrNcGMrO

With the draft guidance issued today on presenting quantitative information in direct to consumer promotion and ads for drugs, the #FDA’s aim is to make sure consumers have clear, easy to understand information about the benefits and risks of a product https://t.co/4tChBzaEvq

Today #FDA issued draft guidance today to provide advice on how quantitative effectiveness and risk information in consumer ads, such as the results of clinical trials, can be presented in a way that’s more easily understood by consumers https://t.co/4tChBzaEvq

RT @FDA_Drug_Info: National Prescription Drug Take Back Day is October 27, 2018. Learn how to dispose of unused & expired drugs safely… https://t.co/2CqNcrguir

RT @FDASpox: FLAGGING: @FDAOncology has posted a list of molecular targets for which drugs are currently being developed for adu… https://t.co/9qOcxznwTX

I'm pleased to announce #FDA's new partnership with @DHSgov to increase coordination of responses to medical device cybersecurity threats https://t.co/oCOIwvVVZf FDA has been proactive in developing a robust program to address medical device cybersecurity concerns.... https://t.co/u5CTAXG4L5

RT @RareDiseases: “Without patient perspective, there is no good medical product development.” Rachel Sherman @US_FDA Principal Deput… https://t.co/O37tSGOVPz

UPDATE: As #HurricaneMichael moved through the Southeast, #FDA identified additional FDA-related facilities in MD, DE, VA & the Carolinas. There are more than 3,500 FDA-regulated facilities in those states that we’ve begun assessing in addition to firms identified in FL, AL & GA.

RT @FDAPatientinfo: Samir Shaikh, Deputy Director of the Patient Affairs Staff (PAS) discusses FDA’s Rare Disease Patient Listening Ses… https://t.co/1dD8M8oJpf

To date, there are no national shortages reported of any critical medical products as a result of Hurricane Michael. #FDA continues to work closely with HHS partners to assist in #HurricaneMichael response.

We have updated information for farmers in MD, DE, VA and the Carolinas on crops harvested from flooded fields for food: https://t.co/EjRCHaB4gw  and animal food: https://t.co/VIAF1a7EKZ

RT @FDATobacco: October is #HealthyLungMonth Smoking can result in lung cancer. Discover more about smoking and lung cancer here:… https://t.co/yapoV0raD6

RT @SeemaCMS: .@CMSGov, we’ve been working hard to ensure seniors benefit from more choices, more benefits & lower costs. For 201… https://t.co/vd95j5pTgO

A heart wrenching obituary that captures the pain, personal devastation, and lost promise dispensed by the opioid crisis https://t.co/ezLFW5LjCQ

FDA’s Patient Listening Sessions allow patients and their advocates to share your experience living with a rare disease with #FDA review staff. Contact the Patient Affairs Staff to learn more #NORDSummit https://t.co/3hQDiDUFk0

My op ed in The Washington Post with @SecAzar on the steps we’re taking to reverse what’s become an epidemic trajectory of kids use of e-cigarettes @washingtonpost https://t.co/DoqUjDet6Z

We issued new guidances to modernize drug development, providing greater clarity and direction as drug developers pursue the next generation of therapies and treatments for patients https://t.co/zdXvVmVhfY https://t.co/REiToTODH6

.@SecAzar: "I am very disturbed by what I am seeing in terms of e-cigarette and vaping use among our teens." https://t.co/tdUbNH9IUK

For fiscal year 2018, the #FDA approved more generic drugs applications than ever before – 971 final and tentative approvals -- beating the agency’s previous record for FY2017. About 12% of these approvals were for typically higher-cost, complex products https://t.co/yHUQnqWcBG

2/2 This list shows molecular targets for which drugs are currently being developed for adult #cancer indications and whose targets may also contribute to the growth and/or progression of #PediatricCancer: https://t.co/kPVocxr11f

THREAD 1/2 Pediatric cancer drug development has lagged far behind development of cancer drugs for adults. To help industry develop new drug and biologic products for children with cancer, @FDAOncology has posted a list of molecular targets. https://t.co/wrqrNcGMrO

With the draft guidance issued today on presenting quantitative information in direct to consumer promotion and ads for drugs, the #FDA’s aim is to make sure consumers have clear, easy to understand information about the benefits and risks of a product https://t.co/4tChBzaEvq

Today #FDA issued draft guidance today to provide advice on how quantitative effectiveness and risk information in consumer ads, such as the results of clinical trials, can be presented in a way that’s more easily understood by consumers https://t.co/4tChBzaEvq

RT @FDA_Drug_Info: National Prescription Drug Take Back Day is October 27, 2018. Learn how to dispose of unused & expired drugs safely… https://t.co/2CqNcrguir

RT @FDASpox: FLAGGING: @FDAOncology has posted a list of molecular targets for which drugs are currently being developed for adu… https://t.co/9qOcxznwTX

I'm pleased to announce #FDA's new partnership with @DHSgov to increase coordination of responses to medical device cybersecurity threats https://t.co/oCOIwvVVZf FDA has been proactive in developing a robust program to address medical device cybersecurity concerns.... https://t.co/u5CTAXG4L5